SILVER SPRING, Md., Feb. 16, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Amtagvi, the first cellular therapy indicated for the treatment of adult patients with a type of skin cancer (melanoma) that is unable to be removed with surgery (unresectable) or has…
FDA Approves First Cellular Therapy to Treat Patients with Unresectable or Metastatic Melanoma
This post was originally published on this site